fashion -WSS

fashion

author：knowledge 2025-09-03 03:44:21 - browse：34539

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Former Pear Therapeutics executives start new VC firm

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

France's anti

Grail's uphill battle for Medicare to cover its cancer screening test

EU fines Illumina $475 million over Grail acquisition

California store owner shot dead in dispute over displaying Pride flag: Police

Study: Spinal cord stimulation helps patients with paralysis walk again

focus

fashion

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Listen: Vivek Ramaswamy's star turn & leaky drug data

Cancer drug shortages should be causing more outrage

Blinken talks high

Jerome Adams on the need for new antivirals for Covid

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

New air purifier tech could be key to improving indoor air quality

Republicans love RFK Jr. What's that tell us about health in 2024?

As demand for Covid shots wanes, Moderna seeks its next success

Antibody drugs appear effective. Now can we make enough of them?

hotspot

Former Pear Therapeutics executives start new VC firm

CDC says it’s too soon to assess risk posed by Covid subvariant

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

A Greenpeace activist is fined for crash

France's anti

hotspot

hotspot

Wikipedia

leisure time